Automation in Therapeutic Antibody Development:
Current Trends, Challenges and Solutions

Read Whitepaper

Monoclonal antibody (mAb) development is a complex and challenging process, with bottlenecks present from preclinical development to manufacturing.

Key challenges include labor-intensive tasks like cell line development, extensive safety and pharmacokinetic profiling, and the need to meet regulatory requirements.

These factors can prolong the time it takes to bring novel mAb therapies to market.

Let’s Talk


Whitepaper: Read More About Automation in Therapeutic Antibody Development

Automation in Therapeutic Antibody Development: Current Trends, Challenges and Solutions

Automation offers a promising solution to these challenges by: 

  • Accelerating decision-making
  • Enhancing quality control
  • Streamlining development processes

This whitepaper explores the latest progress in mAb development and highlights how automation can expedite the journey from bench to bedside.

 

Read Whitepaper




Let’s Talk

Automation platforms and precision instruments can streamline development—from early-stage research to analysis—helping to ensure a steady pipeline of therapeutic mAbs reach patients in need faster. Let’s talk about how we can help you overcome manual barriers, minimize downtime and reduce time to market.

Learn More

Future of Bioprocessing

Vi-CELL BLU Analyzer Integration with Sartorius Ambr® 250 High Throughput Bioreactor & Ambr® 15 Cell Culture Systems

Automated Bioreactor Sample Delivery to the Vi-CELL BLU Cell Viability Analyzer

Process Development

 

Our Team is Ready to Help

Let’s talk about how we can help you overcome manual barriers, minimize downtime and reduce time to market.

 

Stay up to date with our newsletter

Receive timely updates on your favorite topics from the experts at Beckman Coulter Life Sciences

© 2000-2024 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. All other trademarks are the property of their respective owners.

NOT ALL PRODUCTS ARE AVAILABLE IN ALL COUNTRIES. PRODUCT AVAILABILITY AND REGULATORY STATUS DEPENDS ON COUNTRY REGISTRATION PER APPLICABLE REGULATIONS The listed regulatory status for products correspond to one of the below: IVD: In Vitro Diagnostic Products. These products are labeled "For In Vitro Diagnostic Use." ASR: Analyte Specific Reagents. These reagents are labeled "Analyte Specific Reagent. Analytical and performance characteristics are not established." CE-IVD, CE: Products intended for in vitro diagnostic use and conforming to the In Vitro Diagnostic Regulation (IVDR) (EU) 2017/746. (Note: Devices may be CE marked to other directives.) RUO: Research Use Only. These products are labeled "For Research Use Only. Not for use in diagnostic procedures." LUO: Laboratory Use Only. These products are labeled "For Laboratory Use Only." No Regulatory Status: Non-Medical Device or non-regulated articles. Not for use in diagnostic or therapeutic procedures.